Trial Profile
A prospective, non-randomized, three-month follow-up study to evaluate the effect of bevacizumab injection on contrast sensitivity and macular thickness in eyes with macular edema from central retinal vein occlusion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Oedema
- Focus Therapeutic Use
- 07 Dec 2015 New trial record